Tag: CAT

reduced hospital time and costs Xarelto

Real-world analysis confirms benefit of Xarelto in treating CAT as apixaban

Head-to-head observational analysis showed Xarelto as effective in treating cancer-associated thromboembolism (CAT) as apixaban. The Janssen Pharmaceutical Companies of Johnson & Johnson have announced observational...